Pregled po CROSBI profilu: Vlatko Pejša (CROSBI Profil: 16491, MBZ: 221244)
Pronađeno 134 radova
-
1.(KroHem) Mitrović, Zdravko; Dujmović, Dino; Jakšić, Ozren; Bašić-Kinda, Sandra; Gaćina, Petar; Periša, Vlatka; Prka, Željko; Dreta, Barbara; Galušić Davor; Holik, Hrvoje et al.Dose-adjusted EPOCH and rituximab (DA-EPOCH-R) in older patients with high-risk aggressive diffuse large B-cell lymphoma: A real-life multicenter study by the Croatian Cooperative Group for Hematologic diseases (KroHem) // European journal of haematology, 111 (2023), 13957, 7 doi:10.1111/ejh.13957 (međunarodna recenzija, članak, znanstveni)
-
2.Lucijanić, Marko; Huzjan Korunić, Renata; Sedinić, Martina; Kovačević, Stjepan; Atić, Armin; Pejša, Vlatko; Kušec, RajkoBaseline and progressive adipopenia in newly diagnosed patients with diffuse large B-cell lymphoma with unfavorable features are associated with worse clinical outcomes // Leukemia & lymphoma, 63 (2022), 7; 1556-1565 doi:10.1080/10428194.2022.2034160 (međunarodna recenzija, članak, znanstveni)
-
3.Sabljić, Anica; Sedinić Lacko, Martina; Kušec, Rajko; Pejša, Vlatko; Lucijanić, MarkoNo Evident Prognostic Benefit of Statin Use in Diffuse Large B-Cell Lymphoma Patients with Unfavorable Disease Features Treated with R-DA- EPOCH // Pharmacology, 107 (2022), 11-12; 623-627 doi:10.1159/000526625 (međunarodna recenzija, kratko priopcenje, znanstveni)
-
4.Galušić, Davor; Bašić-Kinda, Sandra; Pijuk, Anđela; Milunović, Vibor; Dreta, Barbara; Franjić, Neven; Coha, Božena; Sinčić-Petričević, Jasminka; Gaćina, Petar; Pejša, Vlatko et al.Efficacy and Safety of Obinutuzumab-chemotherapy Combinations in Front-line Treatment of Follicular Non-Hodgkin Lymphoma During the COVID-19 Pandemic: A Study of KROHEM, the Croatian Cooperative Group for Hematologic Diseases // HemaSphere, 6 (2022), 12; e807, 6 doi:10.1097/HS9.0000000000000807 (međunarodna recenzija, članak, znanstveni)
-
5.Lucijanić, Marko; Huzjan Korunić, Renata; Ivić, Marija; Fazlić Džankić, Amina; Jonjić, Željko; Mitrović, Zdravko; Prka, Željko; Piršić, Mario; Jakšić, Ozren; Gaćina, Petar et al.Psoas muscle index at the time of diagnosis might reflect the prognosis of classical Hodgkinʼs lymphoma patients // Wiener klinische Wochenschrift, 134 (2022), 1-2; 80-82 doi:10.1007/s00508-021-01850-x (međunarodna recenzija, kratko priopcenje, znanstveni)
-
6.Lucijanić, Marko; Huzjan Korunić, Renata; Sedinić, Martina; Kušec, Rajko; Pejša, VlatkoMore pronounced muscle loss during immunochemotherapy is associated with worse clinical outcomes in newly diagnosed patients with diffuse large B-cell lymphoma with unfavorable features // Therapeutics and clinical risk management, 17 (2021), 1037-1044 doi:10.2147/tcrm.s323749 (međunarodna recenzija, članak, znanstveni)
-
7.Lucijanić, Marko; Huzjan Korunić, Renata; Ivić, Marija; Fazlić Džankić, Amina; Kušec, Rajko; Pejša, VlatkoPerirenal and subcutaneous fat differently affect outcomes in newly diagnosed classical Hodgkin lymphoma patients // Hematological oncology, 39 (2021), 4; 575-579 doi:10.1002/hon.2887 (međunarodna recenzija, pismo uredniku, znanstveni)
-
8.Lucijanić, Marko; Huzjan Korunić, Renata; Sedinić, Martina; Kušec, Rajko; Pejša, VlatkoPrognostic impact of psoas muscle index in patients with diffuse large B-cell lymphoma might be dependent on the immunochemotherapy type // Leukemia & lymphoma, 62 (2021), 10; 2535-2538 doi:10.1080/10428194.2021.1919667 (međunarodna recenzija, pismo uredniku, znanstveni)
-
9.Bašić-Kinda, Sandra; Hude, Ida; Ranković, Ena; Ostojić-Kolonić, Slobodanka; Pejša, Vlatko; Radman, Ivo; Bogeljić-Patekar, Martina; Jakšić, Ozren; Dubravčić, Klara; Franić-Šimić, Ivana; Aurer, IgorComparison of different schedules of rituximab and chlorambucil in previously untreated chronic lymphocytic leukemia: a retrospective study of Krohem // Journal of cancer science and clinical therapeutics, 5 (2021), 4; 426-433 doi:10.26502/jcsct.5079128 (međunarodna recenzija, članak, znanstveni)
-
10.Lucijanić, Marko; Krečak, Ivan; Galušić, Davor; Sedinić, Martina; Holik Hrvoje; Periša, Vlatka; Morić Perić, Martina; Zekanović, Ivan; Štoos- Veić, Tajana; Pejša, Vlatko; Kušec, RajkoHigher serum uric acid is associated with higher risks of thrombosis and death in patients with primary myelofibrosis // Wiener klinische Wochenschrift, 133 (2021), 3-4; 97-103 doi:10.1007/s00508-020-01802-x (međunarodna recenzija, članak, znanstveni)
-
11.Aurer, Igor; Jakšić, Ozren; Basic-Kinda, Sandra; Mišura Jakobac, Karla; Sinčić-Petričević, Jasminka; Novaković Coha, Sabina; Galušić, Davor; Holik, Hrvoje; Valković, Toni; Županić-Krmek, Dubravka et al.Feasibility of obinutuzumab (G) combined with higher doses of chlorambucil (Clb) for frontline treatment of CLL: a retrospective non-interventional study of KroHem, the Croatian Cooperative Group for Hematologic Diseases // XVIII International Workshop on Chronic Lymphocytic Leukemia 2019 / Leukemia & lymphoma, 61(S1)
Edinburgh, Ujedinjeno Kraljevstvo, 2020. str. 111-112 doi:10.1080/10428194.2020.1732667 (poster, međunarodna recenzija, prošireni sažetak, stručni) -
12.Lucijanic, Marko; Galusic, Davor; Soric, Ena; Sedinic, Martina; Cubela, Marta; Huzjan Korunic, Renata; Pejsa, Vlatko; Kusec, RajkoRuxolitinib treatment improves muscle mass in patients with myelofibrosis // Annals of Hematology, 100 (2020), 4; 1105-1106 doi:10.1007/s00277-020-04243-8 (međunarodna recenzija, pismo uredniku, znanstveni)
-
13.Aurer, Igor; Jakšić, Ozren; Bašić-Kinda, Sandra; Mišura Jakobac, Karla; Sinčić- Petričević, Jasminka; Novaković Coha, Sabina; Galušić, Davor; Holik, Hrvoje; Valković, Toni; Županić-Krmek, Dubravka et al.Podnošljivost kombinacija obinutuzumaba i viših doza klorambucila u prvoj liniji liječenja kronične limfocitne leukemije // Bilten Krohema, 12 (2020), 1; 23-23 (podatak o recenziji nije dostupan, članak, stručni)
-
14.Pejsa, Vlatko; Lucijanic, Marko; Vrkljan Vuk, Anamarija; Stoos-Veic, Tajana; Jaksic, Ozren; Jonjic, Željko; Pirsic, Mario; Prka, Željko; Ivic, Marija; Fazlic Dzankic, Amina; Mitrovic , ZdravkoProlonged methylprednisolone premedication prior to obinutuzumab in patients with chronic lymphocytic leukemia // Leukemia & lymphoma, 61 (2020), 4; 934-939 doi:10.1080/10428194.2019.1702182 (međunarodna recenzija, članak, znanstveni)
-
15.Pejša, Vlatko; Jakšić, Branimir; Ostojić Kolonić, Slobodanka; Bašić Kinda, Sandra; Coha, Božena; Gverić- Krečak, Velka; Jakšić, Ozren; Sinčić-Petričević, Jasminka; Gaćina, Petar; Kardum-Skelin, Ika et al.Smjernice za liječenje kronične limfocitne leukemije // Bilten Krohema, 11 (2019), 1; 4-7 (podatak o recenziji nije dostupan, članak, stručni)
-
16.Ledinski Fičko, Sanja; Pejša, Vlatko; Zadnik, VesnaHealth-related Quality of Life in Croatian General Population and Multiple Myeloma Patients Assessed by the EORTC QLQ-C30 and EORTC QLQ-MY20 Questionnaires // Radiology and oncology, 53 (2019), 3; 337-347 doi:10.2478/raon-2019-0047 (međunarodna recenzija, članak, znanstveni)
-
17.Radman, Ivo; Vodanović, Marijo; Mandac-Rogulj, Inga; Roganović, Jelena; Petranović, Duška; Valković, Toni; Ostojić Kolonić, Slobodanka; Pejša, Vlatko; Kušec, Rajko; Aurer, IgorSmjernice Hrvatskog društva za hematologiju HLZ-a i KROHEM-a za zbrinjavanje anemije uzrokovane manjkom željeza // Liječnički vjesnik, 141 (2019), 1-2; 1-13 doi:10.26800/lv-141-1-2-1 (recenziran, članak, stručni)
-
18.Lucijanic, Marko; Prka, Zeljko; Pejsa, Vlatko; Stoos-Veic, Tajana; Lucijanic, Jelena; Kusec, RajkoPrognostic implications of low transferrin saturation in patients with primary myelofibrosis // Leukemia Research, 66 (2018), 89-95 doi:10.1016/j.leukres.2018.01.017 (međunarodna recenzija, članak, znanstveni)
-
19.Lucijanic, Marko; Prka, Zeljko; Jaksic, Ozren; Mitrovic, Zdravko; Vrkljan, Anamarija; Pejsa, VlatkoBendamustine-based conditioning prior to autologous stem cell transplantation is associated with high rate of febrile neutropenia and higher mortality // American Journal of Hematology, 94 (2018), 2; E42-E43 doi:10.1002/ajh.25340 (međunarodna recenzija, kratko priopcenje, znanstveni)
-
20.Pejsa, Vlatko; Lucijanic, Marko; Jonjic, Zeljko; Prka, Zeljko; Vukorepa, GoranaProgressive multifocal leukoencephalopathy developing after obinutuzumab treatment for chronic lymphocytic leukemia // Annals of Hematology, 98 (2018), 6; 1509-1510 doi:10.1007/s00277-018-3552-x (međunarodna recenzija, pismo uredniku, znanstveni)
-
21.Jakšić, Branimir; Pejša, Vlatko; Ostojić- Kolonić, Slobodanka; Kardum-Skelin, Ika; Bašić-Kinda, Sandra; Coha, Božena; Gverić- Krečak, Velka; Vrhovac, Radovan; Jakšić, Ozren; Aurer, Igor et al.Guidelines for Diagnosis and Treatment of Chronic Lymphocytic Leukemia. Krohem B-Cll 2017 // Acta clinica Croatica, 57 (2018), 1; 190-215 (recenziran, članak, stručni)
-
22.Lucijanić, Marko; Čičić, David; Štoos‑Veić, Tajana; Pejša, Vlatko; Lucijanić, Jelena; Fazlić Džankić, Amina; VLasac Glasnović, Josipa; Sorić, Ena; Skelin, Marko; Kušec, RajkoElevated Neutrophil–to–Lymphocyte-ratio and Platelet–to–Lymphocyte Ratio in Myelofibrosis: Inflammatory Biomarkers or Representatives of Myeloproliferation Itself? // Anticancer Research, 38 (2018), 5; 3157-3163 doi:10.21873/anticanres.12579 (međunarodna recenzija, članak, znanstveni)
-
23.Jakšić, Branimir; Pejša, Vlatko; Ostojić- Kolonić, Slobodanka; Kardum-Skelin, Ika; Bašić- Kinda, Sandra; Coha, Božena; Gverić- Krečak, Velka; Vrhovac, Radovan; Jakšić, Ozren; Aurer, Igor et al.Guidelines for Diagnosis and Treatment of Chronic Lymphocytic Leukemia. Krohem B-Cll 2017. // Acta clinica Croatica, 57 (2018), 1; 190-215 doi:10.20471/acc.2018.57.01.27 (međunarodna recenzija, članak, stručni)
-
24.Lucijanić, Marko; Mitrović, Zdravko; Čičić, David; Prka, Željko; Pejša, Vlatko; Livun, Ana; Štoos‑Veić, Tajana; Romić, Željko; Živković, Marcela; Lucijanić, Iva et al.Increased mean platelet volume (MPV) is an independent predictor of inferior survival in patients with primary and secondary myelofibrosis // International journal of hematology, 107 (2018), 2; 166-172 doi:10.1007/s12185-017-2348-4 (podatak o recenziji nije dostupan, članak, znanstveni)
-
25.Lucijanić, Marko; Veletić, Ivo; Rahelić, Dario; Pejša, Vlatko; Čičić, David; Skelin, Marko; Livun, Ana; Tupek, Katarina Marija; Štoos-Veić, Tajana; Lucijanic, Tomo et al.Assessing serum albumin concentration, lymphocyte count and prognostic nutritional index might improve prognostication in patients with myelofibrosis // Wiener klinische Wochenschrift, 130 (2018), 3/4; 126-133 doi:10.1007/s00508-018-1318-z (međunarodna recenzija, članak, znanstveni)
-
26.Pejša, Vlatko; Prka, Željko; Lucijanić, Marko; Mitrović, Zdravko; Piršić, Mario; Jakšić, Ozren; Ajduković, Radmila; Kušec, RajkoRituximab with dose-adjusted EPOCH as first-line treatment in patients with highly aggressive diffuse large B-cell lymphoma and autologous stem cell transplantation in selected patients // Croatian Medical Journal, 58 (2017), 1; 40-48 doi:10.3325/cmj.2017.58.40 (međunarodna recenzija, članak, znanstveni)
-
27.Zupančić-Šalek, Silva; Pulnić, Dražen; Ostojić- Kolonić, Slobodanka; Pejša, Vlatko; Valković, Toni; Nemet, DamirSMJERNICE ZA DIJAGNOSTIKU I LIJEČENJE PRIMARNE IMUNOSNE TROMBOCITOPENIJE U ODRASLIH // Lijec Vjesn, 139 (2017), 192-198 (domaća recenzija, pregledni rad, stručni)
-
28.Lucijanić, Marko; Livun, Ana; Štoos-Veić, Tajana; Pejša, Vlatko; Jakšić, Ozren; Čičić, David; Lucijanić, Jelena; Romić, Željko; Orehovec, Biserka; Aralica, Gorana et al.High absolute basophil count is a powerful independent predictor of inferior overall survival in patients with primary myelofibrosis // Hematology, 23 (2017), 4; 201-207 doi:10.1080/10245332.2017.1376843 (međunarodna recenzija, članak, znanstveni)
-
29.Lucijanić, Marko; Livun, Ana; Tupek, Katarina Marija; Štoos-Veić, Tajana; Aralica, Gorana; Geček, Iva; Pejša, Vlatko; Kušec, RajkoHeat shock protein 27 (HSP27/HSPB1) expression is increased in patients with primary and secondary myelofibrosis and may be affecting their survival // Leukemia & lymphoma, 58 (2017), 10; 2497-2500 doi:10.1080/10428194.2017.1296146 (međunarodna recenzija, članak, znanstveni)
-
30.Mitrovic Zdravko; Dujmovic Dino; Pejša Vlatko; Duletic-Nacinovic Antica; Ostojic-Kolonic Slobodanka; Radman Ivo; Basic-Kinda Sanda; Gacina Pero; Ajdukovic-Stojsavljevic Radmila; Skare- Librenjak Ljubica et al.OUTCOME OF OLDER PATIENTS WITH B-LARGE CELL LYMPHOMA (B-LCL)-AN OBSERVATIONAL STUDY OF KROHEM, THE CROATIAN COOPERATIVE GROUP FOR HEMATOLOGICAL DISEASES // 21st Congress of the European Hematology Association Copenhagen, Denmark, June 9–12, 2016
Kopenhagen, Danska, 2016. 1, 993 doi:10.3324/%25x (poster, međunarodna recenzija, prošireni sažetak, znanstveni) -
31.Lucijanić, Marko; Livun, Ana; Tomasović- Lončarić, Čedna; Štoos-Veić, Tajana; Pejša, Vlatko; Jakšić, Ozren; Prka, Željko; Kušec, RajkoCanonical Wnt/β-Catenin Signaling Pathway Is Dysregulated in Patients With Primary and Secondary Myelofibrosis // Clinical Lymphoma Myeloma & Leukemia, 16 (2016), 9; 523-526 doi:10.1016/j.clml.2016.06.004 (međunarodna recenzija, članak, znanstveni)
-
32.Lucijanić, Marko; Pejša, Vlatko; Jakšić, Ozren; Mitrović, Zdravko; Tomasović-Lončarić, Čedna; Stoos-Veic, Tajana; Prka, Željko; Piršić, Mario; Hariš, Višnja; Vasilj, Tamara; Kušec, RajkoThe Degree of Anisocytosis Predicts Survival in Patients with Primary Myelofibrosis // Acta haematologica, 136 (2016), 2; 98-100 doi:10.1159/000445247 (međunarodna recenzija, kratko priopcenje, znanstveni)
-
33.Lucijanić, Marko; Pejša, Vlatko; Jakšić, Ozren; Mitrović, Zdravko; Tomasović-Lončarić, Čedna; Štoos-Veić, Tajana; Prka, Željko; Piršić, Mario; Hariš, Višnja; Vasilj, Tamara; Kušec, RajkoThe Degree of Anisocytosis Predicts Survival in Patients with Primary Myelofibrosis // Acta haematologica, 136 (2016), 2; 98-100 doi:10.1159/000445247 (međunarodna recenzija, kratko priopcenje, znanstveni)
-
34.Lucijanić, Marko; Lasan-Trcic, Ružica: Kušec, Rajko; Pejša, Vlako; Štoos-Veić, Tajana; Jakšić, OzrenLoss of response to azacitidine is associated with deletion 12p13 in a patient with myelodysplastic syndrome with unique translocation t(13 ; 17)(q12 ; q25) after prior breast cancer and acute promyelocytic leukemia // Annals of hematology, 94 (2015), 9; 1617-1619 doi:10.1007/s00277-015-2428-6 (međunarodna recenzija, pismo, znanstveni)
-
35.Lucijanić, Marko; Pejša, Vlatko; Mitrović, Zdravko; Štoos-Veić, Tajana; Livun, Ana; Jakšić, Ozren; Vasilj, Tamara; Piršić, Mario; Hariš, Višnja; Prka, Željko; Kušec, RajkoHemochromatosis gene mutations may affect the survival of patients with myelodysplastic syndrome // Hematology (Luxembourg), 21 (2015), 3; 170-174 (međunarodna recenzija, članak, znanstveni)
-
36.Mitrović, Z; Aralica, G; Tomasović, Č; Štoos Veić, T; Ilić, I; Ries, S; Pejša, VUtjecaj „safe-cut“ igle za biopsiju kosti na adekvatnost cilindara kosti i citološkog razmaza // LIJEČ VJESN 2014 ; 136 (suppl 1):
Rovinj, Hrvatska, 2014. str. 137-137 (poster, recenziran, sažetak, stručni) -
37.Lasan Trcic, Ruzica; Kardum-Skelin, Ika; Planinc-Peraica, Ana; Ostojic Kolonic, Slobodanka; Jaksic, Branimir; Ajdukovic, Radmila; Kusec, Rajko; Pejsa, Vlatko; Labar, Boris; Sertic, DubravkaKaryotypic characterisation in a series of 573 patients with chronic myeloid leukemia // Liječnički vjesnik / Planinc-Peraica, Ana ; Hecimovic, Ana (ur.).
Zagreb: Printera grupa, Zagreb, 2014. str. 70-70 (predavanje, međunarodna recenzija, sažetak, znanstveni) -
38.Piršić, Mario; Prka, Željko; Livun, Ana; Lucijanić, Marko; Jonjić, Ž; Mitrović, Zdravko; Kušec, Rajko; Pejša, VlatkoRijedak slučaj transformacije JAK2+ esencijalne trombocitoze (JAK2+ ET) u Ph+ kroničnu mijeloičnu leukemiju (Ph+ KML) // Liječnički vjesnik / Anić (ur.).
Zagreb, 2014. str. 117-117 (poster, domaća recenzija, sažetak, znanstveni) -
39.Jakšić, Ozren; Sever , Matjaz; Basic-Kinda, Sandra; Bojanic, Ines; Jurenec, Silvana; Maricic, I; Dzepina, G; Aurer, Igor; Pretnar, Joze; Labar, Boris et al.Recruitment of CD34+cells during large and standard volume apheresis after mobilization with or without plerixafor // Bone marrow transplantation
London, Ujedinjeno Kraljevstvo, 2013. str. S189-S190 (poster, međunarodna recenzija, sažetak, znanstveni) -
40.Aurer, Igor; Gašparov, Slavko; Kralik, Marko; Balenović, Antonija; Huić, Dražen, Santek, Fedor Duletić-Načinović, Antica; Pejša Vlatko; Ostojić-Kolonić, Slobodanka; Joachim Grah, JosipDIJAGNOSTIKA I LIJEČENJE LIMFOMA – DRUGI HRVATSKI KONSENZUS // Liječnički vijesnik, 135 (2013), 63-76 (podatak o recenziji nije dostupan, pregledni rad, znanstveni)
-
41.Štoos-Veić, Tajana; Tadić, Mario; Aralica, Gorana; Tomasović-Lončarić, Čedna; Pejša, Vlatko; Piršić, Mario; Kušec, RajkoMultidisciplinary aproach to the diagnosis of deep seated T-cell lymphoma causing jaundice. // XVIth Meeting of the European Association of Haematopathology. J Hematopathol 2012 ; 5
Lisabon, Portugal, 2012. str. 234-234 (poster, međunarodna recenzija, sažetak, stručni) -
42.Šenjug, Petar; Švenda, Dario; Trutin Ostović, Karmen; Miletić, Zorana; Tomasović-Lončarić, Čedna; Štoos-Veić, Tajana; Gizdić, Branimir; Aralica, Gorana; Pejša, Vlatko; Jakšić, OzrenProcjena broja plazma stanica u koštanoj srži histologijom, citologijom i protočnom citometrijom pri monoklonalnim poremećajima plazma stanica. // Liječnički vjesnik 2012 ; 134 ; supp 2
Zagreb, Hrvatska, 2012. str. 86-86 (poster, sažetak, stručni) -
43.Šenjug, Petar; Švenda, Dario; Tomasović-Lončarić, Čedna; Štoos-Veić, Tajana; Aralica, Gorana; Pejša, Vlatko; Jakšić, OzrenAssessment of bone marrow infiltration by fine needle aspiration biopsy in monoclonal plasma cell disorders. // 23rd Ljudevit Jurak International Symposium on Comparative Pathology. Conference papers
Zagreb, Hrvatska, 2012. str. 51-52 (poster, sažetak, stručni) -
44.Pejša, Vlatko; Prka ŽeljkoKronična limfocitna leukemija // Medix : specijalizirani medicinski dvomjesečnik, 100 (2012), 208-211 (podatak o recenziji nije dostupan, pregledni rad, stručni)
-
45.Prka, Željko; Tomasović-Lončarić, Čedna; Pejša, Vlatko; Nevajda, Branimir; Kušec, RajkoDiffuse skin hyperpigmentation in CD30+ lymphoproliferation // Annals of Saudi medicine, 32 (2012), 3; 318-320 doi:10.5144/0256-4947.2012.318 (međunarodna recenzija, članak, znanstveni)
-
46.Lasan Trcic, Ružica; Kardum, Ika; Jaksic, Branimir; Jaksic, Ozren; Kusec, Rajko; Pejsa, Vlatko; Zadro, Renata; Batinic, Drago; Labar, Boris; Begovic, Davor.A Philadelphia-negative Chronic Myeloid Leukemia with a BCR/ABL Fusion Gene. // Liječnički vjesnik, 133 (2011), Suppl 94; 90-90 (podatak o recenziji nije dostupan, članak, znanstveni)
-
47.Jakšić, Ozren; Gizdić, Branimir; Štoos-Veić, Tajana; Jakšić-Pandžić, Vlatka; Kušec, Rajko; Pejša, Vlatko; Jakšić, BranimirDifferent Pattern of Expression of CD52, CD20 and CXCR-4 in Peripheral Blood, Bone Marrow and Lymph Nodes in B-Cell Chronic Lymphocytic Leukemia (B- CLL) // 23 ASH Annual Meeting : abstracts ; u: Blood
East Lansing (MI): American Society of Hematology, 2011. str. 1657-1657 (poster, međunarodna recenzija, sažetak, znanstveni) -
48.Marusic Vrsalovic, Maruška; Livun, Ana; Duic, Ivana; Ajdukovic, Radmila; Hariš, Višnja, Jakšić, Ozren; Pejša, Vlatko; Kušec, Rajko Kušec RBCR-ABL KINASE DOMAIN MUTATIONS IN PRIMARY AND SECONDARY RESISTANT IMATINIB-TREATED CHRONIC MYELOID LEUKEMIA // PROGRAM AND ABSTRACTS THE SEVENTH CONFERENCE IN FORENSICS, ANTHROPOLOGIC AND MEDICAL GENETICS AND MAYO CLINIC LECTURES IN TRANSLATIONAL MEDICINE
Bol, Hrvatska, 2011. (poster, međunarodna recenzija, sažetak, znanstveni) -
49.Crncec, Ilija; Musani, Vesna; Marusic Vrsalovic, Maruška; Livun, Ana; Pejsa, Vlatko; Jaksic, Ozren; Haris, Višnja; Ajdukovic, Radmila; Štoos Veić, Tajana; Kušec, Rajko Stoos Veic T, Kusec R.NPM1 mutations in AML detected by fragment analysis and Sanger sequencing (PP04) // Liječnički vijesnik
Zagreb, Hrvatska, 2011. (poster, međunarodna recenzija, sažetak, znanstveni) -
50.Serić, D; Perić, Z; Sinčić-Petričević, J; Lozić, D; Mandac-Rogulj, I; Duletić Naćinović, A; Gverić-Krečak, V; Ćorović-Arneri, E; Pejsa, V; Suvić-Križanić, V et al.Croatian CML Registry based on European LeukemiaNet CML Registry // Liječn Vjesn 2011 ; 133(suppl. 4)
Dubrovnik, Hrvatska, 2011. (poster, domaća recenzija, sažetak, stručni)
